Wikipedia -WSS

Wikipedia

author：fashion 2025-08-25 07:28:50 - browse：256

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： New study raises questions about niacin and heart health

WSS

Medicare Advantage enrollment hits roughly 33.4 million

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

IRA could hurt research into orphan drugs for rare diseases

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

In 'major milestone,' FDA approves first cell therapy for solid tumors

Surprise medical billing ban raises prices elsewhere

knowledge

Wikipedia

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Congress may force more Covid

Apple is now the first public company to be valued at $3 trillion

How to make the FDA’s new prescription one

New air purifier tech could be key to improving indoor air quality

In 'major milestone,' FDA approves first cell therapy for solid tumors

Medical leaders decry Supreme Court decision on affirmative action

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Continuity nursing helped my family in our darkest PICU moments

Researchers tackle phage therapy hurdles for wider adoption

Wikipedia

White House touts steps to stem shortages of cancer treatments

A new drug could help frostbite victims avoid its ravages

Regeneron agrees to White House price limits on anti

Elevance, SCAN deals highlight health insurer acquisition scrutiny

How to make the FDA’s new prescription one

Flagship Pioneering startup Sonata Therapeutics lays off 21

focus

hotspot

entertainment

leisure time